Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: April 29, 2017

DrugPatentWatch Database Preview


« Back to Dashboard

Which patents cover Divalproex Sodium, and when can generics launch?

Divalproex Sodium is a drug marketed by Zydus Pharms Usa Inc, G And W Labs Inc, Wockhardt, Mylan, Prinston Inc, Anchen Pharms, Nu Pharm, Aurobindo Pharma Ltd, Amneal Pharms, Teva, Orchid Hlthcare, Dr Reddys Labs Ltd, Unichem Labs Ltd, Reddys, Actavis Labs Fl Inc, Upsher Smith, Lupin, Sandoz, Impax Labs, and Sun Pharm Inds. and is included in thirty NDAs.

The generic ingredient in DIVALPROEX SODIUM is divalproex sodium. There are seventeen drug master file entries for this compound. Fifty-three suppliers are listed for this compound. Additional details are available on the divalproex sodium profile page.

Summary for Tradename: DIVALPROEX SODIUM

Suppliers / Packagers: see list50
Bulk Api Vendors: see list33
Clinical Trials: see list949
Patent Applications: see list2,795
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:DIVALPROEX SODIUM at DailyMed

Pharmacology for Tradename: DIVALPROEX SODIUM

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
divalproex sodium
TABLET, DELAYED RELEASE;ORAL090062-002Mar 17, 2009ABRXNoNo► Subscribe► Subscribe
Aurobindo Pharma Ltd
divalproex sodium
TABLET, DELAYED RELEASE;ORAL090554-003Apr 21, 2011ABRXNoNo► Subscribe► Subscribe
Dr Reddys Labs Ltd
divalproex sodium
CAPSULE, DELAYED REL PELLETS;ORAL078979-001Jan 23, 2009ABRXNoNo► Subscribe► Subscribe
Impax Labs
divalproex sodium
TABLET, EXTENDED RELEASE;ORAL078791-001May 6, 2009ABRXNoNo► Subscribe► Subscribe
Unichem Labs Ltd
divalproex sodium
TABLET, DELAYED RELEASE;ORAL079163-003Apr 5, 2011ABRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Find generic sources and suppliers
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus